Rectal epithelial apoptosis does not predict response to sulindac treatment or polyp development in presymptomatic familial adenomatous polyposis patients

Cancer Epidemiol Biomarkers Prev. 2002 Jul;11(7):670-1.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adenoma / drug therapy*
  • Adenoma / pathology
  • Adenoma / prevention & control*
  • Adenomatous Polyposis Coli / drug therapy*
  • Adenomatous Polyposis Coli / pathology
  • Adolescent
  • Adult
  • Apoptosis / drug effects
  • Biopsy, Needle
  • Colonic Neoplasms / drug therapy*
  • Colonic Neoplasms / pathology
  • Colonic Neoplasms / prevention & control*
  • Epithelium / drug effects
  • Epithelium / pathology
  • Female
  • Humans
  • Intestinal Mucosa / drug effects
  • Intestinal Mucosa / pathology
  • Male
  • Middle Aged
  • Precancerous Conditions / pathology
  • Predictive Value of Tests
  • Rectum / drug effects
  • Rectum / pathology
  • Reference Values
  • Sulindac / administration & dosage*
  • Treatment Outcome

Substances

  • Sulindac